Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Sheena Alice Linehan has worked on the following 7 EPO patent applications which have been published in the last five years:

EP11722243

CHIMERIC OSPA GENES, PROTEINS, AND METHODS OF USE THEREOF

IPC classification:
A61K 39/02, C07K 14/20
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11720967

OSPA CHIMERAS AND USE THEREOF IN VACCINES

IPC classification:
A61K 39/02, C07K 14/20
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11741727

NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE

IPC classification:
A61K 47/48
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12198754

Cell culture processes

IPC classification:
C07K 14/00, C12P 21/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12198392

Cell culture processes

IPC classification:
C07K 14/00, C12P 21/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13150822

Lyophilized recombinant VWF formulations

IPC classification:
A61K 9/08, A61K 9/19, A61K 38/16, A61K 38/36, A61K 47/12, A61K 47/18, A61K 47/26, A61K 48/00
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hoffmann Eitle PartmbB
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11720255

BIFUNCTIONAL MOLECULES FOR INACTIVATING HIV AND BLOCKING HIV

IPC classification:
A61K 38/16, C07K 14/16
Agent:
Sheena Alice Linehan, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature